## Abstract Recently, 2 modeling strategies have been proposed and shown to be useful to increase precision of up‐to‐date cancer survival estimates and to predict cancer patient survival: modeled period analysis and modeled cohort analysis. We aimed to compare the performance of both types of model
Up-to-date cancer survival: Period analysis and beyond
✍ Scribed by Hermann Brenner; Timo Hakulinen
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- French
- Weight
- 205 KB
- Volume
- 124
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Since its introduction in 1996, period analysis has been shown to be useful for deriving more up‐to‐date cancer survival estimates, and the method is now increasingly used for that purpose in national and international cancer survival studies. However, period analysis, like other commonly employed methods, is just a special case from a broad class of design options in the analysis of cancer survival data. Here, we explore a broader range of design options, including 2 model‐based approaches, for deriving up‐to‐date estimates of 5‐ and 10‐year relative survival for patients diagnosed in the most recent 5‐year interval for which data are available. The performance of the various designs is evaluated empirically for 20 common forms of cancer using more than 50‐year long time series of data from the Finnish Cancer Registry. Period analysis as well as the 2 model‐based approaches, one using a “cohort‐type model” and another using a “period‐type model”, all performed better than traditional cohort or complete analysis. Compared with “standard period analysis”, the cohort‐type model further increased up‐to‐dateness of survival estimates, whereas the period‐type model increased their precision. While our analysis confirms advantages of period analysis over traditional methods in terms of up‐to‐dateness of cancer survival data, further improvements are possible by flexible use of model‐based approaches. © 2008 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Transatlantic cancer survival comparisons are scarce and involve mostly aggregate European data from the late 1980s. We compare the levels of cancer patient survival achieved in Germany and the United States (US) by the beginning of the 21st century, using data from the Cancer Registry
## Abstract Model‐based projections were shown to be useful for deriving most up‐to‐date population‐based cancer survival estimates. However, the performance of these projections, which can be derived by various approaches, has only been evaluated in very few cancer patient populations. Using incid
For the article cited above, an error was made in listing the last author's name. The correct name is Song Iy Han. We apologize to the readers for any confusion caused by this error.
## Abstract A deficit in colorectal cancer survival in Denmark and in the UK compared to Sweden, Norway and Finland was found in the EUROCARE studies. We set out to explore if these differences still exist. Patients diagnosed with colorectal cancer as their first invasive cancer at age 15–89 in the